Process for attenuated varicella zoster virus vaccine production

Details Process for attenuated varicella zoster virus vaccine production Process for attenuated varicella zoster virus vaccine production

1992-06-04

1994-11-01

Nucker, Christine M.

Chemistry: molecular biology and microbiology

Spore forming or isolating process

4352351, 4242301, C12N 508

Patent

active

053607368

ABSTRACT:
A live, attenuated varicella zoster virus vaccine is produced with enhanced yield of VZV. The new process makes mass production of a live VZV vaccine more practical.

REFERENCES:
patent: 3555149 (1971-01-01), Buynak et al.
patent: 3660565 (1972-05-01), Plotkin
patent: 3915794 (1975-10-01), Zygraich et al.
patent: 3919411 (1975-11-01), Glass et al.
patent: 3961046 (1976-06-01), Cerini
patent: 3985615 (1976-10-01), Kube
patent: 4000256 (1976-12-01), Hilleman et al.
patent: 4147772 (1979-04-01), McAleer et al.
patent: 4252792 (1981-02-01), Blades
patent: 4273762 (1981-06-01), McAleer et al.
patent: 4324861 (1982-04-01), Kan
patent: 4337242 (1982-06-01), Markus et al.
patent: 4338335 (1982-07-01), McAleer et al.
patent: 4772466 (1988-09-01), Allison et al.
patent: 5024836 (1991-06-01), McAleer et al.
Brunell, 1967, "Separahon of infections Varicella-zoster . . . " Virology 31(4): 732-734.
Iscove and Melchers et al., 1978, "Complete Replacement of Serum Albumin . . . " J. E. M. 147: 923-933.
Kielian, et al., 1986, "Kinetics of endosome acidification detected . . . " EMBO J. 5: 3103-3109.
Iscove, 1984, "Culture of Lymphocytes and Hemopoietic . . . " Methods for Serum-Free Culture of Neuronal and Lymphoid Cells, pp. 169-185.
Takahashi, et al., 1974, "Live vaccine used to prevent . . . " The Lancet Nov. 30, 1288-1290.
Grose, et al, 1981, "Cryopreservation of varicella-zoster . . . " Intervirology 15: 154-160.
Buus, et al., 1984, "Chloroquine inhibits accessory cell presentation . . . " Acta Pathol. Microbiol. Scand. Sect. C Immunol. 92(5): 285-292 (abstract).
Hayakawa et al., J. Infect. Dis. 149, 956-967 (1984).
Hondo et al., Arch. Ges. Virus 40: 397-399 (1973).
Howell & Miller J. Clin. Microbiol. 18: 658-662 (1983).
Husson, J. Biol. Stand. 15: 385-388 (1987.
Languet et al., Comp. Immun. Microbiol. Infect. Dis. 8: 285-295 (1985).
Majer et al., Dev. Biol. Stand. 36: 285-289 (1976).
Mariner et al., Vet. Microbiol. 21: 195-209 (1990).
McAleer et al., J. Biol. Stand 8: 281-287 (1980).
Michalski et al., Infect. Immun. 14: 135-143 (1976).
Popa & Repanovici Acta Virol. 21: 280-287 (1977).
Schmidt & Lennette Infect. Immun. 12: 606-613 (1975).
Scott & Woodside J. Clin. Microbiol. 4: 1-5 (1976).
Shiraki et al., Acta Virol. 33: 565-568 (1989).
Takahashi et al., Postgrad. Med. J. 61 (Suppl. 4): 37-46 (1985).
Yaminishi et al., Infect. Immun. 28: 536-541 (1980).
Takayama & Oya Biken J., 24: 109-118 (1981).
Boehringer Mannheim Catalog, p. 648 (1991).
DeCourcy and Storrie, Esp. Cell Res. 192, 52-60 (1991).
Cohn et al., J. Exp. Med. 129, 201-222 (1969).
Iscove et al., Exp. Cell Res. 126, 121-126 (1980).
Farrant et al., Hormonally Defined Media pp. 300-303 Fisher & Wieser (Ed). Springer-Verlby (1982).
Fazekas de St. Groth J. Imm. Methods, 57 121-136 (1983).
Muzik et al., In vitro 18 515-524 (1982).
Weiss et al., In vitro 16(7), 616-628 (1980).
Miles Inc., Catalog Description of EX-CYTE*
Mann, G. F., Develop. Biol. Stand., 37, 149-152 (1977).
Wood and Minor, Biologicals 18, 143-146 (1990).
Enders, J. F. et al., Proc. Soc. Exp. Biol. Med. 86, 277-286 (1954).
Arbeter, A. M. et al., Pediatrics 76 Suppl. 742-746 (1976).
Physicians Desk Reference, 1991, pp. 1401-1403.
Krah, D. L. et al., J. Vir. Method 27, pp. 319-326 (1990).
P. J. Provost et al., Vaccine 9, 111-116 (1991).
Asano & Takahashi Biken J. 21: 15-23 (1978).
Bovarnick et al., J. Bacteriol. 59: 509-522 (1950).
Calnek et al., Appl. Microbiol. 20: 723-726 (1970).
de S. Lopes et al., J. Biol. Stand 16: 71-76 (1988).
de Rizzo et al., Bull. Pan. Am. Health Org. (US) 23: 299-305.

Affiliated with

Also associated with

Rating

Process for attenuated varicella zoster virus vaccine production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for attenuated varicella zoster virus vaccine production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for attenuated varicella zoster virus vaccine production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1802077